Search

everythinglearnresearchcommunity

for

Search:↓

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Pro-IGF-II improves muscle repair in old mice.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

Gelatin microspheres with stem cells speed up healing in diabetic wounds.

Polydeoxyribonucleotide (PDRN) may help lighten skin and treat hyperpigmentation.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

FDG PET/CT scans can change cancer treatment plans for dogs.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Using a fractional laser can stimulate hair growth, but the intensity and duration of inflammation are crucial. Too much can cause ulcers and scarring. Lower beam energy and fewer treatments are recommended to avoid damage.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

A woman with severe angioedema improved significantly after treatment with rituximab.

Effective treatments for severe alopecia areata are still lacking.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Botulinum toxin injections may help treat hair loss by blocking harmful secretion in hair follicles.